Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh · Delayed Price · Currency is BDT 204.90
+1.30 (0.64%)
At close: Nov 27, 2025
DSE:SQURPHARMA Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Net Income | 25,280 | 23,968 | 20,926 | 18,980 | 18,157 | 15,947 | Upgrade |
Depreciation & Amortization | 2,199 | 2,201 | 2,319 | 2,310 | 1,835 | 1,882 | Upgrade |
Loss (Gain) From Sale of Assets | -26.14 | -29.06 | 208 | 79.8 | -53.49 | -34.43 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -177.04 | Upgrade |
Loss (Gain) on Equity Investments | -3,222 | -3,194 | -2,595 | -2,523 | -2,011 | -1,291 | Upgrade |
Other Operating Activities | -5,282 | -5,647 | -4,927 | -4,654 | -3,838 | -3,330 | Upgrade |
Change in Accounts Receivable | 713.06 | 314.83 | 869.7 | -1,262 | -522.93 | -115.84 | Upgrade |
Change in Inventory | 507.81 | -477.05 | -354.95 | -4,177 | -968.71 | -1,558 | Upgrade |
Change in Accounts Payable | -41.6 | -80.58 | 453.67 | 375.77 | -40.18 | 127.76 | Upgrade |
Change in Income Taxes | - | - | - | -555.41 | 338.83 | -405.36 | Upgrade |
Change in Other Net Operating Assets | 414.21 | 245.58 | 1,629 | -29.96 | -22.88 | -69.56 | Upgrade |
Operating Cash Flow | 20,543 | 17,302 | 18,529 | 8,546 | 12,875 | 10,976 | Upgrade |
Operating Cash Flow Growth | 51.97% | -6.62% | 116.82% | -33.63% | 17.29% | 2.01% | Upgrade |
Capital Expenditures | -5,988 | -6,177 | -4,181 | -2,861 | -6,183 | -3,798 | Upgrade |
Sale of Property, Plant & Equipment | 79.69 | 84.14 | 97.44 | 78.33 | 130.7 | 80.13 | Upgrade |
Investment in Securities | -7,317 | -4,124 | -7,221 | -858.01 | -1,416 | -798.2 | Upgrade |
Other Investing Activities | 6,018 | 6,320 | 4,256 | 4,428 | 3,499 | 3,239 | Upgrade |
Investing Cash Flow | -7,207 | -3,897 | -7,049 | 787.69 | -3,970 | 3,607 | Upgrade |
Long-Term Debt Issued | - | - | - | 72.7 | 1,811 | 103.71 | Upgrade |
Total Debt Issued | - | - | - | 72.7 | 1,811 | 103.71 | Upgrade |
Long-Term Debt Repaid | - | -603.58 | -557.89 | - | - | - | Upgrade |
Total Debt Repaid | -695.69 | -603.58 | -557.89 | - | - | - | Upgrade |
Net Debt Issued (Repaid) | -695.69 | -603.58 | -557.89 | 72.7 | 1,811 | 103.71 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 0.5 | Upgrade |
Common Dividends Paid | -9,711 | -9,709 | -9,275 | -8,803 | -5,302 | -3,923 | Upgrade |
Other Financing Activities | - | - | - | -32.23 | -262.5 | - | Upgrade |
Financing Cash Flow | -10,407 | -10,313 | -9,833 | -8,762 | -3,754 | -3,819 | Upgrade |
Foreign Exchange Rate Adjustments | 107.97 | 290.81 | 271.89 | 560.97 | 447.1 | 35.61 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 | Upgrade |
Net Cash Flow | 3,037 | 3,383 | 1,919 | 1,132 | 5,598 | 10,800 | Upgrade |
Free Cash Flow | 14,555 | 11,125 | 14,348 | 5,685 | 6,692 | 7,178 | Upgrade |
Free Cash Flow Growth | 79.59% | -22.46% | 152.37% | -15.04% | -6.78% | -17.66% | Upgrade |
Free Cash Flow Margin | 18.16% | 14.58% | 20.47% | 9.37% | 11.62% | 14.16% | Upgrade |
Free Cash Flow Per Share | 16.42 | 12.55 | 16.18 | 6.41 | 7.55 | 8.10 | Upgrade |
Cash Interest Paid | 226.55 | 226.55 | 246.14 | 87.68 | 0.03 | 0.01 | Upgrade |
Cash Income Tax Paid | 4,052 | 4,052 | 4,320 | 5,127 | 4,494 | 4,595 | Upgrade |
Levered Free Cash Flow | 10,766 | 8,567 | 11,476 | 2,948 | 4,800 | 10,672 | Upgrade |
Unlevered Free Cash Flow | 10,877 | 8,702 | 11,629 | 3,022 | 4,800 | 10,672 | Upgrade |
Change in Working Capital | 1,593 | 2.78 | 2,598 | -5,648 | -1,216 | -2,021 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.